Foltabs 800
NDC Package 68308-325-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Foltabs 800 is this combination of vitamins provides vitamin B-6, vitamin B-12 and folic acid to people who do not have enough of these vitamins for good health. Marketed by Mayne Pharma Inc, this product is identified by NDC 68308-325.

Identification & Billing

NDC Package Code
68308-325-10
Package Description
60 TABLET in 1 BOTTLE
Product Code
68308-325
11-Digit Billing Format
68308032510

Clinical Specifications

Proprietary Name
Foltabs 800
Dosage Form
-
Usage Information
This combination of vitamins provides vitamin B-6, vitamin B-12 and folic acid to people who do not have enough of these vitamins for good health.

Regulatory & Marketing

Labeler Name
Mayne Pharma Inc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-01-2009
End Marketing Date
06-30-2019
Listing Expiration
06-30-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68308-325-10 identifies a specific commercial package of 60 tablet in 1 bottle of Foltabs 800, labeled by Mayne Pharma Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mayne Pharma Inc on January 01, 2009. The current certification is valid through June 30, 2019.

What are the primary indications for this medication?

This combination of vitamins provides vitamin B-6, vitamin B-12 and folic acid to people who do not have enough of these vitamins for good health.

How is this Mayne Pharma Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68308032510. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68308-325-10
11-Digit CMS (5-4-2)
68308-0325-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.